T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
Conditions: Breast Cancer; Metastatic Breast Cancer Intervention: Drug: Trastuzumab-Deruxtecan (T-DXd) Sponsors: MedSIR; Daiichi Sankyo, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | HER2 | Herceptin | Neurology | Research